HPLC, UHPLC
HPLC-MS analysis reveals blood monitoring as 'essential' for generic tacrolimus recipients
Aug 20 2010
Tacrolimus is used to suppress the immune response in individuals after they receive a transplanted organ, to prevent their body from rejecting the alien tissue.
Findings presented at the International Congress of the Transplant Society (ICTS) reveal that a recently approved generic version of the drug is safe for use in recipients of kidneys and liver tissue.
However, the HPLC-MS analysis indicated a need to assess concentrations of the drug in the bloodstream of patients.
Some 37 per cent of participants experienced a shift in concentration of more than a fifth after changing to the generic drug.
Across the board, the reduction in tacrolimus concentration averaged 15 per cent, the scientists saw.
The ICTS event took place in Vancouver, Canada on August 15th-19th.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
May 15 2024 Birmingham, UK
May 19 2024 Brno, Czech Republic
May 21 2024 Lagos, Nigeria